{"pmid":32369626,"title":"Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.","text":["Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.","Autoimmune hemolytic anemia (AIHA) can rarely complicate infections. We wish to report a case of simultaneous presentation of COVID-19 disease and warm AIHA. A 46 year old female with a medical history of congenital thrombocytopenia not on therapy presented with dyspnea and cough to the Emergency Department. She was found to have pneumonia after a CT chest revealed a dense left upper lobe consolidation with minimal surrounding ground glass opacities and no evidence of pulmonary embolism. (Figure) She had normal vital signs and pulse oximetry on ambient air. She was initiated on azithromycin 500mg day one then 250 mg daily and discharged home.","Br J Haematol","Lopez, Chris","Kim, Jeremy","Pandey, Apurva","Huang, Ted","DeLoughery, Thomas G","32369626"],"abstract":["Autoimmune hemolytic anemia (AIHA) can rarely complicate infections. We wish to report a case of simultaneous presentation of COVID-19 disease and warm AIHA. A 46 year old female with a medical history of congenital thrombocytopenia not on therapy presented with dyspnea and cough to the Emergency Department. She was found to have pneumonia after a CT chest revealed a dense left upper lobe consolidation with minimal surrounding ground glass opacities and no evidence of pulmonary embolism. (Figure) She had normal vital signs and pulse oximetry on ambient air. She was initiated on azithromycin 500mg day one then 250 mg daily and discharged home."],"journal":"Br J Haematol","authors":["Lopez, Chris","Kim, Jeremy","Pandey, Apurva","Huang, Ted","DeLoughery, Thomas G"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369626","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/bjh.16786","locations":["Simultaneous Onset"],"e_drugs":["Azithromycin"],"topics":["Case Report"],"weight":1,"_version_":1666138496245432320,"score":9.490897,"similar":[{"pmid":32374906,"title":"Autoimmune hemolytic anemia associated with Covid-19 infection.","text":["Autoimmune hemolytic anemia associated with Covid-19 infection.","Among patients with SARS-CoV-2 infection (also known as Covid-19), pneumonia, respiratory failure, and acute respiratory distress syndrome are frequently encountered complications (Zhou et al, 2020). Although the pathophysiology underlying severe Covid-19 remains poorly understood, accumulating evidence argue for hyperinflammatory syndrome causing fulminant and fatal cytokines release associated with disease severity and poor outcome (Mehta et al, 2020). However, the spectrum of complications is broader and include among others various auto-immune disorders such as autoimmune thrombocytopenia, Guillain-Barre and antiphospholipid syndrome (Zhang et al, 2020; Zulfiqar et al, 2020; Toscano et al, 2020). In this report we describe 7 patients from 6 French and Belgian Hospitals who developed a first episode of autoimmune hemolytic anemia (AIHA) during a Covid-19 infection.","Br J Haematol","Lazarian, Gregory","Quinquenel, Anne","Bellal, Mathieu","Siavellis, Justine","Jacquy, Caroline","Re, Daniel","Merabet, Fatiha","Mekinian, Arsene","Braun, Thorsten","Damaj, Gandhi","Delmer, Alain","Cymbalista, Florence","32374906"],"abstract":["Among patients with SARS-CoV-2 infection (also known as Covid-19), pneumonia, respiratory failure, and acute respiratory distress syndrome are frequently encountered complications (Zhou et al, 2020). Although the pathophysiology underlying severe Covid-19 remains poorly understood, accumulating evidence argue for hyperinflammatory syndrome causing fulminant and fatal cytokines release associated with disease severity and poor outcome (Mehta et al, 2020). However, the spectrum of complications is broader and include among others various auto-immune disorders such as autoimmune thrombocytopenia, Guillain-Barre and antiphospholipid syndrome (Zhang et al, 2020; Zulfiqar et al, 2020; Toscano et al, 2020). In this report we describe 7 patients from 6 French and Belgian Hospitals who developed a first episode of autoimmune hemolytic anemia (AIHA) during a Covid-19 infection."],"journal":"Br J Haematol","authors":["Lazarian, Gregory","Quinquenel, Anne","Bellal, Mathieu","Siavellis, Justine","Jacquy, Caroline","Re, Daniel","Merabet, Fatiha","Mekinian, Arsene","Braun, Thorsten","Damaj, Gandhi","Delmer, Alain","Cymbalista, Florence"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374906","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/bjh.16794","keywords":["b-cell lymphoproliferative disorder","covid-19","autoimmune hemolytic anemia"],"locations":["Belgian"],"countries":["Belgium"],"countries_codes":["BEL|Belgium"],"topics":["Case Report"],"weight":1,"_version_":1666138496370212865,"score":389.9678},{"pmid":32453861,"title":"Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","text":["Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated.","Br J Haematol","Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco","32453861"],"abstract":["This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated."],"journal":"Br J Haematol","authors":["Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453861","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16883","keywords":["ankirin 1","autoantibodies","autoimmunity","covid-19","molecular mimicry","severe acute respiratory syndrome coronavirus 2"],"topics":["Mechanism"],"weight":1,"_version_":1667983494521815040,"score":374.92093},{"pmid":32460350,"title":"Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).","text":["Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).","Cold agglutinin syndrome (CAS) is a rare disorder associated with infection, autoimmune disorders, and lymphoid malignancies. We are present a case of CAS associated with SARS-CoV-2 that causes COVID-19. A 46-year-old female presented with severe anemia and positive SARS-CoV-2 RNA PCR. Direct Coombs test was positive to IgG and complement. LDH was elevated and haptoglobin was undetectable. Peripheral smear revealed RBC agglutination, marked polychromasia, and many nucleated RBCs. Unfortunately, as a result of her severe hypoxemia, patient went into pulseless electrical activity before receiving transfusion and subsequently died. We postulate that CAS can be associated with COVID-19, and ongoing surveillance is required for potential association.","Br J Haematol","Zagorski, Emily","Pawar, Tushar","Rahimian, Shoja","Forman, Daniel","32460350"],"abstract":["Cold agglutinin syndrome (CAS) is a rare disorder associated with infection, autoimmune disorders, and lymphoid malignancies. We are present a case of CAS associated with SARS-CoV-2 that causes COVID-19. A 46-year-old female presented with severe anemia and positive SARS-CoV-2 RNA PCR. Direct Coombs test was positive to IgG and complement. LDH was elevated and haptoglobin was undetectable. Peripheral smear revealed RBC agglutination, marked polychromasia, and many nucleated RBCs. Unfortunately, as a result of her severe hypoxemia, patient went into pulseless electrical activity before receiving transfusion and subsequently died. We postulate that CAS can be associated with COVID-19, and ongoing surveillance is required for potential association."],"journal":"Br J Haematol","authors":["Zagorski, Emily","Pawar, Tushar","Rahimian, Shoja","Forman, Daniel"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460350","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16892","topics":["Case Report"],"weight":1,"_version_":1667967698864177152,"score":242.27507},{"pmid":32420629,"title":"Evans syndrome in a patient with COVID-19.","text":["Evans syndrome in a patient with COVID-19.","Evans syndrome (ES) is a rare condition characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia (ITP). While the precise pathophysiology is not entirely understood, it is believed that dysregulation of the immune system is a primary contributor to the condition. ES has been observed in viral infections including hepatitis C, cytomegalovirus, varicella-zoster, and Epstein-Barr viruses (1-4). Initial cases of coronavirus disease 2019 (COVID-19) were first described in early December 2019 and has now spread to a global pandemic. While knowledge about COVID-19 continues to evolve, clinicians have reported hematologic complications associated with the virus.","Br J Haematol","Li, Monica","Nguyen, Charles B","Yeung, Zachary","Sanchez, Katherine","Rosen, Daniel","Bushan, Sita","32420629"],"abstract":["Evans syndrome (ES) is a rare condition characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia (ITP). While the precise pathophysiology is not entirely understood, it is believed that dysregulation of the immune system is a primary contributor to the condition. ES has been observed in viral infections including hepatitis C, cytomegalovirus, varicella-zoster, and Epstein-Barr viruses (1-4). Initial cases of coronavirus disease 2019 (COVID-19) were first described in early December 2019 and has now spread to a global pandemic. While knowledge about COVID-19 continues to evolve, clinicians have reported hematologic complications associated with the virus."],"journal":"Br J Haematol","authors":["Li, Monica","Nguyen, Charles B","Yeung, Zachary","Sanchez, Katherine","Rosen, Daniel","Bushan, Sita"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420629","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bjh.16846","locations":["Evans"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1667159284511670272,"score":191.29367},{"pmid":32471783,"title":"Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.","text":["Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.","Patients infected with the SARS-CoV-2 virus can present with a wide variety of symptoms including being entirely asymptomatic. Despite having no or minimal symptoms, some patients may have markedly reduced pulse oximetry readings. This has been referred to as \"silent\" or \"apathetic\" hypoxia (Ottestad et al., 2020 [1]). We present a case of a 72-year-old male with COVID-19 syndrome who presented to the emergency department with minimal symptoms but low peripheral oxygen saturation readings. The patient deteriorated over the following days and eventually died as a result of overwhelming multi-organ system failure. This case highlights the utility of peripheral oxygen measurements in the evaluation of patients with SARS-CoV-2 infection. Self-monitoring of pulse oximetry by patients discharged from the emergency department is a potential way to identify patients needing to return for further evaluation.","Am J Emerg Med","Wilkerson, R Gentry","Adler, Jason D","Shah, Nirav G","Brown, Robert","32471783"],"abstract":["Patients infected with the SARS-CoV-2 virus can present with a wide variety of symptoms including being entirely asymptomatic. Despite having no or minimal symptoms, some patients may have markedly reduced pulse oximetry readings. This has been referred to as \"silent\" or \"apathetic\" hypoxia (Ottestad et al., 2020 [1]). We present a case of a 72-year-old male with COVID-19 syndrome who presented to the emergency department with minimal symptoms but low peripheral oxygen saturation readings. The patient deteriorated over the following days and eventually died as a result of overwhelming multi-organ system failure. This case highlights the utility of peripheral oxygen measurements in the evaluation of patients with SARS-CoV-2 infection. Self-monitoring of pulse oximetry by patients discharged from the emergency department is a potential way to identify patients needing to return for further evaluation."],"journal":"Am J Emerg Med","authors":["Wilkerson, R Gentry","Adler, Jason D","Shah, Nirav G","Brown, Robert"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471783","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ajem.2020.05.044","keywords":["covid-19","sars-cov-2","silent hypoxia"],"topics":["Case Report"],"weight":1,"_version_":1668255193305710594,"score":190.83119}]}